|
U.S. GAO Calls for Device Recall Oversight Reform by FDA
The U.S. Food and Drug Administration (FDA) should launch a program to routinely and systematically assess device recall information, and use this program to identify strategies for mitigating health risks presented by defective or unsafe devices, the U.S. Government Accountability Office (GAO) says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives